Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery
NCT ID: NCT04003038
Last Updated: 2025-10-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
80 participants
INTERVENTIONAL
2019-05-02
2026-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
NPWT Reduction Mammaplasty
NCT06725459
ciNPT in Autologous Abdominal Tissue Breast Reconstruction
NCT04985552
ciNPT in Autologous DIEP Flap Breast Reconstruction
NCT05907941
The Effect of Nitroglycerin Ointment, Fluorescent Angiography, and Incisional Negative Pressure Wound Therapy on Mastectomy Skin Flap Perfusion-Related Problems
NCT03716050
Prevention of Postoperative Complications by Negative Pressure Therapy After Complex Breast Cancer Surgery
NCT06265558
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. Determine the impact of negative pressure wound therapy on wound healing as measured by wound dehiscence rate.
II. Long-term follow-up on wound healing complications.
OUTLINE: Patients are randomized to 1 of 2 groups.
GROUP I: Patients receive wound care with a standard dressing (bandage) after surgery for 7 days.
GROUP II: Patients receive negative pressure wound therapy (NPWT) after surgery for 7 days.
After completion of study, patients are followed up at 2 weeks, and at 1 and 3 months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group I (wound care with a standard dressing)
Patients receive wound care with a standard dressing (bandage) after surgery for 7 days.
Wound Care Management
Receive wound care with a standard dressing (bandage)
Group II (NPWT)
Patients receive NPWT after surgery for 7 days.
Negative Pressure Wound Therapy
Receive wound care with NPWT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Negative Pressure Wound Therapy
Receive wound care with NPWT
Wound Care Management
Receive wound care with a standard dressing (bandage)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients are willing and able to give consent.
* Body mass index (BMI) greater than or equal to 30.0.
Exclusion Criteria
* Patients who are suspected or known to be pregnant.
* Known allergy to topical adhesives.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Edward H Chang
Role: PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
M D Anderson Cancer Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Edward I. Chang
Role: primary
Related Links
Access external resources that provide additional context or updates about the study.
MD Anderson Cancer Center Website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2019-02777
Identifier Type: REGISTRY
Identifier Source: secondary_id
2018-0004
Identifier Type: OTHER
Identifier Source: secondary_id
2018-0004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.